Episode 4: Are peptides legal in the U.S. After FDA Category 2?
February 14, 2026 · 11:13
FDA's Category 2 and 503A rules bar many peptides (e.g., BPC-157) from legal pharmacy compounding.
Compounding pharmacies
An overview of compounding pharmacies, how they customize medications like testosterone and other hormones, and what men should know when sourcing TRT and other treatments through these specialized providers.
Most-read topics as podcast episodes
We only record episodes on the topics readers care about most.
Start here
The essentials for compounding pharmacies — then explore the latest posts below.
BPC-157 FDA status in 2026: Compounding and legality
Dr. Susan Carter, MD: Endocrinologist & Longevity Expert
Dec 03, 2025 · 13 min read
As of 2026, BPC-157, CJC-1295, and ipamorelin are not FDA-approved drugs, and all appear on the FDA’s Section 503A “Category 2” list (FDA Category 2 list, accessed February 15, 2026). Thymosin beta-4, which is often marketed online under the nickname “TB-500,” also appears on the FDA’s Section 503A “Category 2” list (FDA Category 2 list, ...